Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS) EPS is poised to hit -0.14 next quarter: How Investors Can Make It Count the Most?
Zack King
Aclaris Therapeutics Inc (NASDAQ: ACRS) flaunted slowness of -4.24% at $2.26, as the Stock market unbolted on Wednesday, before settling ...

Aclaris Therapeutics Inc (ACRS) 20 Days SMA touches 17.21%: The odds favor the bear
Steve Mayer
On Monday, Aclaris Therapeutics Inc (NASDAQ: ACRS) opened higher 8.84% from the last session, before settling in for the closing ...

Aclaris Therapeutics Inc (ACRS) is destined for greater heights as its last quarter sales were 1,780 K
Zack King
Aclaris Therapeutics Inc (NASDAQ: ACRS) on Friday, soared 6.42% from the previous trading day, before settling in for the closing ...





